Abstract
JAK kinase inhibitors are being investigated as a way of managing cytokine storm in severe COVID-19 patients.
Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Worksce.
MeSH terms
-
Animals
-
Azetidines / therapeutic use
-
Betacoronavirus / physiology
-
COVID-19
-
COVID-19 Drug Treatment
-
Clinical Trials as Topic
-
Coronavirus Infections / drug therapy
-
Coronavirus Infections / immunology*
-
Humans
-
Janus Kinase Inhibitors / therapeutic use*
-
Pandemics
-
Pneumonia, Viral / drug therapy
-
Pneumonia, Viral / immunology*
-
Purines
-
Pyrazoles
-
SARS-CoV-2
-
Sulfonamides / therapeutic use
Substances
-
Azetidines
-
Janus Kinase Inhibitors
-
Purines
-
Pyrazoles
-
Sulfonamides
-
baricitinib